Lynparza Breast Cancer Clinical Experience Investigation

  • STATUS
    Not Recruiting
  • End date
    Dec 28, 2021
  • participants needed
    150
  • sponsor
    AstraZeneca
Updated on 19 May 2021
Investigator
AstraZeneca Clinical Study Information Center
Primary Contact
Research Site (0.4 mi away) Contact
+33 other location

Summary

To characterise the development of ADRs of bone marrow depression in patients under actual post-marketing use

Description

To characterise the development of adverse drug reactions (ADRs) of bone marrow depression in patients with unresectable or recurrent BRCA mutated HER2 negative breast cancer who have previously received anticancer chemotherapy under actual post-marketing use.

Details
Condition Breast Cancer
Clinical Study IdentifierNCT03590938
SponsorAstraZeneca
Last Modified on19 May 2021

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note